Construction of tumor-specific toxins using ubiquitin fusion technique. (Q40466420)

20 September 2017

title

Construction of tumor-specific toxins using ubiquitin fusion technique. (English)

1 reference

20 September 2017

2

Jadwiga Chroboczek

1 reference

20 September 2017

Sergey O Tcherniuk

1

1 reference

20 September 2017

Maxim Y Balakirev

series ordinal

3

1 reference

20 September 2017

publication date

1 February 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

11

1 reference

20 September 2017

issue

2

1 reference

20 September 2017

page(s)

196-204

1 reference

Novel approaches to treating the asymptomatic hormone-refractory prostate cancer patient

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Biology of prostate-specific antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Prostate-Specific antigen expression by various tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Use of the complex between prostate specific antigen and alpha 1-protease inhibitor for screening prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Ribosome-inactivating proteins from plants: more than RNA N-glycosidases?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Genetic engineering of an immunotoxin to eliminate pulmonary vascular leak in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Comparative cytotoxicity and pharmacokinetics of antimelanoma immunotoxins containing either natural or recombinant gelonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

The amino-terminal fragment of human urokinase directs a recombinant chimeric toxin to target cells: internalization is toxin mediated.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Binding and cytotoxicity of conjugated and recombinant fusion proteins targeted to the gonadotropin-releasing hormone receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

7 January 2021

Targeted toxins in pain

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Characterization of a saporin isoform with lower ribosome-inhibiting activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

A proteolytic pathway that recognizes ubiquitin as a degradation signal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Deubiquitinating enzymes as cellular regulators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Deubiquitinating enzymes are IN/(trinsic to proteasome function).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Detecting and measuring cotranslational protein degradation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

A ubiquitin-based tagging system for controlled modulation of protein stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Substrate specificity of prostate-specific antigen (PSA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

The Unusual Stability of Saporin, a Candidate for the Synthesis of Immunotoxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Modulation of the intracellular stability and toxicity of diphtheria toxin through degradation by the N-end rule pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Endocytosis of a chimera between human pro-urokinase and the plant toxin saporin: an unusual internalization mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Alpha 2-macroglobulin receptor mediates binding and cytotoxicity of plant ribosome-inactivating proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Cytotoxicity of ribosome-inactivating protein saporin is not mediated through alpha2-macroglobulin receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

A peptide-doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Plasmin-activated doxorubicin prodrugs containing a spacer reduce tumor growth and angiogenesis without systemic toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Potent antitumor activity of a urokinase-activated engineered anthrax toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Biological and biochemical characterization of variant A subunits of cholera toxin constructed by site-directed mutagenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Modified apoptotic molecule (BID) reduces hepatitis C virus infection in mice with chimeric human livers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

The crystal structure of saporin SO6 from Saponaria officinalis and its interaction with the ribosome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Delineation of prognostic biomarkers in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Codominance and toxins: a path to drugs of nearly unlimited selectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Anti-tumor effects and lack of side effects in mice of an immunotoxin directed against human and mouse prostate-specific membrane antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

A novel TARP-promoter-based adenovirus against hormone-dependent and hormone-refractory prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

A novel strategy by the action of ricin that connects phenotype and genotype without loss of the diversity of libraries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

Structural basis for the specificity of ubiquitin C-terminal hydrolases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.009

10.1016/J.YMTHE.2004.10.009

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference